National Jewish Health Interstitial Lung Disease Program — Denver, Colorado

National Jewish Health Interstitial Lung Disease Program is a clinical research site located in Denver, Colorado, United States 80206.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

National Jewish Health Interstitial Lung Disease Program has participated in 2 clinical trials.

Therapeutic areas: Pulmonary Fibrosis of Any Cause, Primary Supporters/Caretakers of Patients With Pulmonary Fibrosis, Pulmonary Fibrosis.

Sponsors: National Jewish Health.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for National Jewish Health Interstitial Lung Disease Program?

National Jewish Health Interstitial Lung Disease Program has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has National Jewish Health Interstitial Lung Disease Program conducted?

National Jewish Health Interstitial Lung Disease Program has 2 clinical trials on record. Their work covers Pulmonary Fibrosis of Any Cause, Primary Supporters/Caretakers of Patients With Pulmonary Fibrosis, Pulmonary Fibrosis.

Is National Jewish Health Interstitial Lung Disease Program accredited by Crixeo Health?

National Jewish Health Interstitial Lung Disease Program has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about National Jewish Health Interstitial Lung Disease Program?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.